Franck's Lab Inc. has recalled approximately 4,155 units of various sterile veterinary injectable medications, including Acepromazine, Amikacin, and Buprenorphine, distributed between November 21, 2011, and May 21, 2012. The recall was initiated after FDA environmental testing discovered microorganisms and fungal growth inside the clean room where these sterile products were prepared and compounded. These products were distributed to veterinary clinics and veterinarians by prescription nationwide and internationally.
The presence of mold and bacteria in injectable medications poses a significant risk of serious infection or illness to animals. Medications meant to be sterile that are contaminated with microorganisms can lead to localized or systemic infections when injected directly into an animal's body.
Veterinary refund and clinical guidance
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response